A leader in vision and driving research
Pioneering age-related macular degeneration research
Advanced optic imaging capabilities
Exploring glaucoma via ocular biomechanics

Inside UAB's high-tech, custom-built approach to eye science

COBB featureThis group is exploring a new paradigm that could revolutionize our understanding of glaucoma and other eye conditions. The approach, ocular biomechanics, applies engineering principles to the eye. 


glaucoma boomThe department is involved in multiple lines of basic and clinical research of glaucoma. That research includes investigations into intraocular, structure and function of the optic nerve head with glaucomatous damage, basic and clinical research into the role of age and race in the development and progression of glaucoma, and health services research into novel care delivery models in increase the accessibility of glaucoma care.

UAB Pilot Program Brings Glaucoma Screening Closer to Home

Glaucoma is a silent disease. It does not hurt, symptoms are slow to develop, and most people do not notice any loss of vision until it is too late.

Age-related macular degeneration

AMD bom

Pioneering research by the UAB Department of Ophthalmology into retinal disorders, specifically age-related macular degeneration, has led to major scientific breakthroughs. Age-related macular degeneration is one of the most common ocular disorders in the U.S., and there is no cure.


4:30 pm-6:00 pm

Volker Hall, VH 301


7:00 am-8:00 am

TBD (will be announced closer to date)


12:00 pm-1:00 pm

Volker Hall Lecture Room C


12:00 pm-1:00 pm

Callahan Eye Hospital, Smith Education Center, 3rd Floor


12:00 pm-1:00 pm

Volker Hall Lecture Room C

Ocular Biomechanics and Biotransport

COBB boomThis program uses principles of engineering to understand the mechanisms underlying the pathophysiology of ocular disease such as glaucoma, myopia, keratoconus, and age-related macular degeneration, as well as the biomechanics of ocular trauma. This exciting, underdeveloped field has the potential for significant breakthroughs in the diagnosis treatment of ocular disease.